Found: 32
Select item for more details and to access through your institution.
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 899, doi. 10.1177/13524585231223880
- By:
- Publication type:
- Article
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 261, doi. 10.1177/13524585231223069
- By:
- Publication type:
- Article
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 236, doi. 10.1177/13524585221139156
- By:
- Publication type:
- Article
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1556, doi. 10.1177/1352458520969145
- By:
- Publication type:
- Article
Efficacy of rituximab in refractory RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 828, doi. 10.1177/1352458518772748
- By:
- Publication type:
- Article
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194115
- By:
- Publication type:
- Article
Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
- Published in:
- Neuroepidemiology, 2017, v. 48, n. 3/4, p. 179, doi. 10.1159/000479516
- By:
- Publication type:
- Article
The radiologically isolated syndrome: revised diagnostic criteria.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 8, p. 3431, doi. 10.1093/brain/awad073
- By:
- Publication type:
- Article
End‐Truncated LAMB1 Causes a Hippocampal Memory Defect and a Leukoencephalopathy.
- Published in:
- Annals of Neurology, 2021, v. 90, n. 6, p. 962, doi. 10.1002/ana.26242
- By:
- Publication type:
- Article
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217319836664
- By:
- Publication type:
- Article
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 7, p. 4019, doi. 10.1007/s00415-024-12289-1
- By:
- Publication type:
- Article
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2216, doi. 10.1007/s00415-024-12266-8
- By:
- Publication type:
- Article
Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 125, doi. 10.1007/s00415-023-11905-w
- By:
- Publication type:
- Article
Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 10, p. 3817, doi. 10.1007/s00415-021-10501-0
- By:
- Publication type:
- Article
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 12, p. 3518, doi. 10.1007/s00415-020-10029-9
- By:
- Publication type:
- Article
High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 4, p. 902, doi. 10.1007/s00415-019-09212-4
- By:
- Publication type:
- Article
Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 5, p. 891, doi. 10.1007/s00415-017-8444-9
- By:
- Publication type:
- Article
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231205954
- By:
- Publication type:
- Article
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231205954
- By:
- Publication type:
- Article
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 8, p. 814, doi. 10.1001/jamaneurol.2024.1961
- By:
- Publication type:
- Article
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 490, doi. 10.1001/jamaneurol.2024.0395
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 1, p. 94, doi. 10.1001/jamaneurol.2019.2670
- By:
- Publication type:
- Article
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2128271, doi. 10.1001/jamanetworkopen.2021.28271
- By:
- Publication type:
- Article
Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-04836-5
- By:
- Publication type:
- Article
Performance of administrative databases for identifying individuals with multiple sclerosis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45384-w
- By:
- Publication type:
- Article
Prognostic impact of epileptic seizures in multiple sclerosis varies according to time of occurrence and etiology.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 12, p. 3537, doi. 10.1111/ene.15551
- By:
- Publication type:
- Article
Evaluation of CSF1R‐related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 1, p. 329, doi. 10.1111/ene.15115
- By:
- Publication type:
- Article
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. 3461, doi. 10.1111/ene.14612
- By:
- Publication type:
- Article
Clinical and radiological activity of secondary progressive multiple sclerosis in a population‐based cohort.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 7, p. 2238, doi. 10.1111/ene.14861
- By:
- Publication type:
- Article
Untreated patients with multiple sclerosis: A study of French expert centers.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 6, p. 2026, doi. 10.1111/ene.14790
- By:
- Publication type:
- Article
The long‐term outcome of MOGAD: An observational national cohort study of 61 patients.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1659, doi. 10.1111/ene.14746
- By:
- Publication type:
- Article